/
PRVCF
$0.01-$0.00 (-22.30%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.04
18% from low
Exchange
OTC Link
OS
Borrow rate
0.40%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.5K | $3.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $4.7K | $779 | $75.2K | $5.1K | $9.9K | $9.9K | $7.0K | $14.4K |
| Gross profit | $10.7K | $2.3K | −$75.2K | −$5.1K | −$9.9K | −$9.9K | −$7.0K | −$14.4K |
| Gross margin | 69.4% | 74.3% | — | — | — | — | — | — |
| R&D | $3.3M | $2.0M | $315.1K | $171.8K | $78.4K | $92.5K | $82 | $232.7K |
| Operating income | −$7.0M | −$3.5M | −$2.1M | −$898.0K | −$1.1M | −$963.0K | −$812.5K | −$3.4M |
| EBITDA | −$11.3M | −$2.8M | −$2.1M | −$830.0K | −$1.0M | −$905.0K | −$752.6K | −$3.3M |
| Net income | −$11.9M | −$3.6M | −$3.8M | −$1.7M | −$1.5M | −$1.3M | −$1.2M | −$1.6M |
| Net margin | -76909.1% | -118079.8% | — | — | — | — | — | — |
| EPS (diluted) | -0.04 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
PREVECEUTICAL MED INC NEW
PREVECEUTICAL MED INC NEW
Held by traders on TradeandTell
No one on the platform currently holds PRVCF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PRVCF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2018-05-23 | 5-for-1 |
Recent trades on TradeandTell
No one on the platform has traded PRVCF yet.
